Investigating the Feasibility of Brief Compassion Focused Therapy in Individuals in Treatment for Opioid Use Disorder by Carlyle, M et al.
Creative Commons CC BY: This article is distributed under the terms of the Creative Commons Attribution 4.0 License  
(http://www.creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission 
provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
https://doi.org/10.1177/1178221819836726
Substance Abuse: Research and Treatment
Volume 13: 1–9
© The Author(s) 2019
DOI: 10.1177/1 7822 81983672
Introduction
Opioid use disorder (OUD) is responsible for most illicit drug-
related deaths worldwide,1 which have recently reached epi-
demic levels.2,3 Rates of psychological trauma, particularly 
those that have occurred in childhood, are disproportionately 
high among those living with substance use disorders.4,5 Such 
experiences include inconsistent parental responsiveness, lack 
of affection, neglect, bullying and abuse,6 all of which are vul-
nerability factors to later developing a substance use disorder.7 
Adverse experiences in early life can interfere with the adaptive 
development of emotion regulation which is typically acquired 
in childhood and adolescence.8 It has been suggested that indi-
viduals may use analgesic drugs such as opioids as a form of 
‘emotional numbing’ to deal with unpleasant emotional states 
when the ability to self-regulate emotions has not been nur-
tured in childhood.8 Unpleasant emotional states that persist 
following experiences of early adversity can include high levels 
of self-criticism, guilt and shame,9-11 all of which are frequently 
reported among those living with addictions.12,13
Compassion has been conceptualised as sensitivity to suffer-
ing in self and others with a commitment to try to alleviate and 
prevent it.14-16 Self-compassion has been shown as protective 
for mental health and well-being.17 It is positively associated 
with improved emotion regulation abilities, and mediates the 
relationship between childhood trauma and later emotional 
dysregulation.18 Self-compassion is also related to reduced drug 
and alcohol use. People with severe alcohol use disorder who 
rate higher in self-compassion have better mental health, longer 
abstinence and lower levels of negative emotional states such as 
stress, depression, anxiety19 and self-criticism.20 Importantly, 
self-compassion was recently shown as inversely related to risk 
of developing a substance use disorder, potentially indicating its 
protective involvement in reducing problematic drug use and 
demonstrating its therapeutic value.21 Treatments aimed at fos-
tering self-compassion have already proven highly successful in 
the treatment of mental health problems, particularly in people 
who express high levels of shame and guilt22 and have histories 
of trauma.23 Thus, it seems plausible that an intervention 
focused on compassion may also help those living with OUD. 
One issue with such treatments, however, is a resistance to 
engage in self-compassion from individuals for whom such 
experiences are alien and often aversive.24 Therefore, this study 
set out to examine the feasibility and acceptability of a brief, 
3-session intervention developed to foster compassion in indi-
viduals in treatment for OUD, currently maintained on opioid 
substitution medication.
Third-wave psychological therapies are being increasingly 
used for treatment-resistant conditions, such as Acceptance 
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and Commitment Therapy (ACT) or Mindfulness-based 
Cognitive Therapy (MBCT). However, the difference 
between these therapies and compassion focused therapy 
(CFT) is the inclusion of an explicit element that fosters the 
fundamental ability to self-soothe by developing the courage 
to engage with difficult emotions. Such self-compassion in 
those with OUD may be particularly beneficial, as external 
substances may be used as a compensatory mechanism to the 
absence of this process25 or to evoke positive emotions that 
have not previously been experienced due to childhood adver-
sity. Compassion focused therapy focuses on helping people 
understand that the human brain has evolved in a way that 
makes it susceptible to rumination, negativity bias and self-
critical self-monitoring.26,27 In therapy, individuals learn to 
shift attention from shaming the self for these difficulties to 
how to work with them compassionately.28 This is particu-
larly relevant in opioid use where users feel large amounts of 
shame both currently around their drug use and historically 
due to trauma. Physiologically, recent research has demon-
strated that CFT leads to improvements in heart rate varia-
bility.29 Heart rate variability is a measure of emotional 
regulation, and therefore, enhancing emotional regulation is 
key to recovery, as users most frequently report taking opioids 
to manage difficult emotions. The current intervention was 
brief to investigate whether it could exert a high impact and 
cost-effective means of treating OUD in drug services. The 
intervention drew on the principles of CFT: a novel treat-
ment formulated to increase levels of self-compassion.30,31 
This study merged principles from 2 leading models in the 
literature: one of which is rooted in evolution and attach-
ment31 while the other is informed by eastern meditative 
traditions.15
Method
Participants and design
This study was a mixed-methods design. Participants were 
allocated to either CFT, active control (relaxation training) or 
waitlist control. Compassion focused therapy and the active 
control group were randomised, and participants were blind to 
whether they were in the active treatment or active control.
The final sample consisted of 38 participants (24 men; 14 
women) aged 22–62 years (M = 39.95, SD = 10.44) currently in 
treatment with drug services and prescribed a daily opioid sub-
stitute medication (OSM: methadone; buprenorphine). All 
participants had a diagnosis of OUD.
The study was advertised as a ‘stress reduction skills course’ 
to reduce preexisting expectations about what the groups 
involved. Data from the waitlist control were collected subse-
quent to the first 2 groups, and this group was offered treat-
ment following their participation. Inclusion criteria were 
above 18 years of age, fluent English speakers and currently 
taking an OSM. Participants were excluded if they had learn-
ing difficulties or neurological impairment, or were illiterate. 
The study was approved by the institutional university ethics 
committee.
Intervention development
The CFT sessions involved a mixture of psychoeducation with 
experiential exercises (see Table 1 for details of the interven-
tion) and were co-created by a team of psychologists, drug 
workers from the local drug service and service users in recov-
ery. The brief format was judged as acceptable by users and key 
workers, and as having a good chance of treatment adherence 
to maximise retention and engagement.
The relaxation training group emulated the experience of 
those in the active treatment group as closely as possible by 
containing a similar weighting of psychoeducation and 
exercises.
Measures
Feasibility. Feasibility was assessed by assessing the percentage 
of individuals agreeing to take part in the study (success crite-
ria: 60%), completing the baseline measures (success criteria: 
70%) and completing follow-up measures (success criteria: 
50%).
Measures. We included quantitative measures to be able to 
assess the feasibility of using such measures in a full trial. Addi-
tional measures were included to pilot the feasibility of the 
design in a larger trial which were questions around opioid pre-
scription and are reported elsewhere.
Obsessive-Compulsive Drug Use Scale (OCDUS). This assessed 
opioid drug craving, with 3 subscales – thoughts and interfer-
ence, desire and control, and resistance to thoughts and inten-
tion33 – and the 3 subscales had good reliability when 
implemented before and after the intervention (thoughts and 
interference – before, after: α = .785, α = .788; desire and control 
– before, after: α = .914, α = .898; resistance to thoughts – 
before, after: α = .874, α = .809).
Depression Anxiety Stress Scale (DASS). This scale measured 
levels of depression, anxiety and stress over the past week, and 
each subscale was shown to have high reliability when it was 
implemented both before and after the intervention (depres-
sion – before, after: α = .922, α = .887; anxiety – before, after: 
α = .816, α = .879; stress – before, after: α = .914, α = .930).41
The Forms of Self-criticising/Attacking and Self-reassuring Scale 
(FSCRS). This measure assessed self-relating via self-criticism 
and self-reassurance/compassion. Subscales include feelings of 
self-inadequacy, ability to self-reassure and self-hate.34 Each 
subscale was shown to have reasonable to high reliability when 
it was implemented both before and after the intervention (self-
inadequacy – before, after: α = .891, α = .874; self-reassurance 
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– before, after: α = .822, α = .852; self-hate – before, after: 
α = .778, α = .858).
Procedure
Both the experimental and active control group attended three 
2-hour sessions held over 3 consecutive weeks (Figure 1). The 
waitlist control group filled out the baseline measures, and 
repeated these on the third week for follow-up.
Prior to participating, participants were contacted for 
screening. This involved a brief assessment of participant’s 
drug use history and their OSM. Once screened, participants 
were allocated to either the CFT, relaxation or waitlist control 
group.
On arrival for session 1, participants provided informed 
consent and were then asked to complete the self-report base-
line measures, which were completed again at the end of ses-
sion 3. Between sessions, participants in the active groups were 
asked to engage in practical activities related to the session 
content by listening to guided recordings on an MP3 device 
and reading a short booklet. After the final session, we asked 
the group to feedback their views on their experiences, and in a 
semi-structured interview, these responses were recorded and 
later transcribed. On completion of the study, participants were 
reimbursed for their time with a voucher.
Statistical analyses
Quantitative data. Data were analysed using the Statistical 
Package for Social Sciences (SPSS), version 23. Data were 
checked for normality and homogeneity. The primary outcome 
was feasibility. An exploratory analysis was conducted of the 
depression and anxiety and craving data with 3 × 2 repeated-
measures analysis of variance (ANOVA) and following up 
large or medium effect sizes with mean differences and 
confidence intervals (CIs) in line with recent recommenda-
tions for reporting pilot studies.35,36
Qualitative analysis. Interview data from session 3 were tran-
scribed and entered into NVivo software (11.1, QSR Interna-
tional). A thematic analysis was conducted of the interview 
data collected from the CFT group; data were coded on 
themes relating to the acceptability and effects of the inter-
vention by 2 independent raters (HR and CM). A single cod-
ing frame was designed which included perceived benefits of 
the intervention and comments on acceptability and feasibil-
ity. Two researchers (HR and CM) then went through the 
coding frame to check for agreement. Each narrative was 
coded according to the appropriate coding frame (HR) with 
inter-rater reliability checked by random selection of 4 inter-
views (CM) and reached high agreement (>95%). Any dis-
crepancies were resolved through discussion or, if an agreement 
could not be met or it was not clear what the participant was 
trying to get across, items were coded as ‘ambiguous’ (<0.02% 
items coded as ambiguous). This procedure produced 12 codes 
(not reported here). These codes were categorised into 4 the-
matic headings.
Results
Demographics
The treatment groups appeared matched in age, sex, years in 
education and indices of past illicit opioid use (see Table 2).
Treatment uptake and adherence
In all, 103 individuals were interested and contacted by the 
research team, where 69 (66.99%) of these individuals agreed 
to take part in the study. Of these, 47 (45% of all approached; 
68.12% of those who agreed to take part) attended the first 
session (baseline), and 38 (80.85% of those attending baseline 
visit) continued to complete the full study and completed all 
measures – CFT: n = 15 (n = 4 discontinued treatment); relaxa-
tion: n = 12 (n = 1 discontinued treatment), and waitlist: n = 11 
(n = 4 lost to follow-up) – with no significant differences in 
number of drop-outs between the groups (χ2= 2.62, n = 38, 
P = .270).
Quantitative analysis
Craving. A 3 × 2 mixed repeated measures ANOVA ‘thoughts 
and intentions around opioid use’ showed a main effect of 
group, F2,34 = 4.88, P = .014, η2 = 0.22, associated with a large 
effect size, where pairwise comparisons revealed that the wait-
list control group had lower scores overall than both the com-
passion (P = .005) and relaxation (P = .021) groups (Figure 2). 
There were no differences in scores from baseline to follow–up, 
F1,34 = 1.26, P = .269, η2 = 0.04, and no interaction between 
group and time, F2,34 = 0.06, P = .939, η2 < 0.01.
Individuals expressed an interest in study via Drug and Alcohol Services
Pre-screened and allocated to a group
Compassion Focused 
Therapy
Relaxation (active 
control) 
Session one (~2 hours) + baseline questionnaires
Waitlist control
Session two (~2 hours)
Session three (~2 hours) + follow up 
questionnaires
Baseline 
questionnaires
Follow up 
questionnaires
Day 0
Day 7
Day 14
Participants recompensed and study end 
Offered treatment
Figure 1. The study procedure.
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For ‘desire and control over opioid use’, there were no main 
effects of group, F2,24 = 1.50, P = .242, η2 = 0.11; time, F1,24 = 0.09, 
P = .769, η2 < 0.01; and no interaction, F2,34 = 1.37, P = .273, 
η2 = 0.10, although the latter was a medium effect size (Figure 
2). Mean difference scores between the compassion and relaxa-
tion group were 0.22 (80% CI: –0.40-0.83), and compassion 
group and the waitlist group were 0.71 (80% CI: 0.15-1.25).
For ‘resistance to thoughts and intentions surrounding opi-
oid use’, there was a difference in scores between baseline and 
follow-up measures that approached significance, F1,24 = 3.43, 
P = .077, η2 = 0.12 (Figure 2). There was also a trend for a dif-
ference in scores between groups, F2,24 = 2.91, P = .074, η2 = 0.20. 
The interaction between group and time, F2,24 = 0.82, P = .452, 
η2 = 0.06, were associated with a medium effect size (Figure 2). 
Table 2. Participant demographics between treatment conditions (means and standard deviations).
COMPASSiON FOCUSED 
THERAPy (N = 15)
RELAXATiON 
(N = 12)
WAiTLiST 
CONTROL (N = 11)
Age 41.07 (12.70) 43.33 (8.27) 34.82 (7.94)
Sex (n = men; women) 11; 4 7; 5 6; 5
years in education (mean rank) 11.77 (2.24) 12.42 (2.23) 11.73 (0.79)
History of mental health problems 12 6 9
Opioid prescription type (n = methadone; buprenorphine; 
morphine)
8, 6, 0 11, 1, 0 8, 2, 1
Opioid prescription dose in mg, /d  
 Methadone 55.63 (60.62) 42.36 (22.54) 51.25 (6.41)
 Buprenorphine 10.00 (4.56) 16.00 (0.00) 14.00 (2.83)
 Morphine 560.00 (0.00) - -
Length taken opioid prescription, y 9.79 (7.70) 6.80 (4.66) 7.39 (5.84)
Last use of illicit opioids (excluding prescription), d (mean rank) 21.46 16.33 16.95
Time since first started using opioids, y 17.41 (12.13) 20.25 (6.47) 14.50 (8.57)
Peak use of opioids following onset, mo 46.46 (29.98) 60.38 (34.56) 24.72 (34.17)
Money spent on opioids at peak use, £ pounds sterling /d 175.80 (144.52) 105.50 (101.80) 88.80 (77.61)
Currently using other illicit substances 7 8 8
Means and standard deviations are provided where data are parametric, otherwise the mean rank is given in cases that are non-parametric. Total counts are given for 
categorical variables.
0
0.5
1
1.5
2
2.5
3
3.5
Baseline Follow up Baseline Follow up Baseline Follow up
Thought and interference Desire and control Resistance
Sc
or
e
Compassion
Relaxation
Waitlist
Figure 2. Scores on craving subscales between each group. There were medium effect sizes for `desire and control’, and `resistance’ subscales which 
were followed up by mean differences and confidence intervals. These indicated that the compassion group were experiencing a larger change in scores 
from baseline to follow up than the waitlist control group, where scores were higher at follow up.
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Mean difference scores between the compassion and relaxation 
groups were 0.29 (80% CI: –0.18-0.77) and between the com-
passion and waitlist group were 0.77 (80% CI: 0.34-1.19).
Depression, anxiety, and stress. A 3 × 2 repeated measures 
ANOVA on depression scores found a main effect of time, 
F1,35 = 6.83, P = .013, η2 = 0.16, where there was an overall 
decrease in scores from baseline to follow-up, associated with a 
large effect size (Table 3). There were no differences between 
groups, F2,35 = 0.97, P = .389, η2 = 0.05, and no interaction, 
F2,35 = 0.01, P = .995, η2 < 0.01.
For anxiety, a similar 3 × 2 repeated-measures ANOVA 
found an interaction between treatment type and time that 
approached statistical significance, F2,33 = 3.08, P = .059, 
η2 = 0.15, and was associated with a large effect size. The mean 
difference scores between the compassion group with relaxa-
tion and waitlist control groups were −0.38 (80% CI: –3.01-
2.25) and 1.40 (80% CI: –1.46-4.27), respectively. There were 
no main effects of group, F2,33 = 0.33, P = .723, η2 = 0.02, or time, 
F1,33 = 0.79, P = .381, η2 = 0.02.
There was a main effect of time on stress, F1,35 = 9.21, 
P = .005, η2 = 0.19, associated with a large effect size, where 
scores reduced from baseline to follow-up in all groups (Figure 
1). There were no differences between groups, F2,35 = 0.31, 
P = .734, η2 = 0.01, or statistically significant interaction, 
F2,35 = 1.91, P = .163, η2 = 0.08; however, the interaction was 
associated with a medium effect size. The mean difference 
scores between the compassion group with relaxation and wait-
list control groups were 1.49 (80% CI: –1.31-4.30) and −0.08 
(80% CI: −2.96-2.80), respectively.
Self-criticism (FSCRS). A 3 × 2 mixed ANOVA were con-
ducted on subscales of self-criticism. There were no significant 
effects on self-hate or self-reassurance and all effect sizes were 
small. The analysis of scores for the self-inadequacy subscale 
found an interaction associated with a medium effect size, 
F2,35 = 0.77, P = .185, η2 = 0.09; however, mean difference scores 
and 80% CIs revealed no further differences between the com-
passion and relaxation or waitlist control group: 0.09 (80% CI: 
–0.58-0.40) and <0.01 (80% CI: –0.49-0.51), respectively.
Qualitative analysis
From transcripts of the interviews that followed the end of the 
final session, a coding framework was developed. Four themes 
emerged from the analysis of the qualitative data. Three themes 
related to the effects of the intervention:
1. Better understanding of oneself and others
A number of participants in the compassion group (n = 7) 
reported as an outcome experiences that could be coded under 
the thematic heading of ‘better understanding of oneself and 
others’:
. . . Yeah, I mean like I used to get annoyed with people that would 
look for sympathy all the time. Now I can understand why they’re 
doing it, because they’re looking for that part of the brain that 
needs like filling up basically. (Participant 9)
2. Increased strength in the face of difficulty
Another emergent theme mentioned by a number of participants 
(n = 6) was categorised as ‘increased strength in the face of difficulty’. 
Participants reported that a positive impact of the CFT was on 
their ability to sit with discomfort and not to over-engage or feel 
the need to shut down or use to numb their emotions:
. . . I mean I come here and I have found a few new tools to help 
me. Well, I’m always going to be going through life and coming 
across stressful situations, I can’t keep running away or doing short 
cuts. (Participant 11)
3. Reducing self-criticism
Another one relating the effects of the intervention was in 
reducing self-criticism (n = 4) in participants, reporting that the 
intervention had given them some enhanced understanding of 
their own self-critical inner voices and an acceptance of their 
own imperfections: ‘It enables you not to be so harsh on your-
self doesn’t it? Because you see that there’s reason for every-
thing, so I can’t be perfect. It’s okay not to be perfect as well’ 
(Participant 13).
4. Intervention was too brief
The other theme emergent from many of the interviews fol-
lowing the final session was the need for more sessions (n = 4): 
‘Personally I think they could have done with a bit more, 
because just basically you’re scratching the surface ain’t you and 
then it’s the end’.
Table 3. Means and standard deviations for scores on anxiety, 
depression and stress scales.
COMPASSiON RELAXATiON WAiTLiST
Depression  
 Baseline 12.13 (5.32) 12.08 (6.96) 14.55 (4.80)
 Follow-up 9.93 (5.32) 10.00 (6.35) 12.55 (4.41)
Anxiety  
 Baseline 9.53 (3.91) 11.17 (6.90) 7.11 (5.69)
 Follow-up 9.05 (5.59) 8.18 (5.38) 8.67 (6.34)
Stress  
 Baseline 12.62 (5.25) 12.29 (7.49) 12.55 (4.16)
 Follow-up 11.49 (6.01) 8.83 (6.13) 11.73 (5.37)
8 Substance Abuse: Research and Treatment 
Discussion
The current study piloted a novel intervention aimed at foster-
ing compassion in those with OUD. In relation to the primary 
aim of the study, a short-course of CFT in opioid drug users 
appears to be feasible in this population. The results of the study 
suggest that the intervention is feasible, and may warrant fur-
ther investigation in a larger randomised control trial. Retention 
rates were high: of those who attended the first session, 81% 
continued to complete the full study. The attrition rate did not 
differ between groups. Attrition rates during CFT in other 
groups have been previously reported to be high in some cases, 
particularly among non-clinical groups.24 Treating oneself with 
compassion can feel alien, and has the potential to cause dis-
tressing emotional reactions in those with histories of abuse and 
neglect, thus causing individuals to discontinue treatment.24 
Despite this, our study had particularly high retention for this 
population, with similar mindfulness-based interventions in 
opioid users reporting retention rates between 45% and 75%.37 
As CFT had equally good retention as relaxation, it may be a 
promising approach for opioid users with trauma history.
Thematic analyses of interview data suggested positive 
effects from individuals in 3 areas: reducing self-criticism, fac-
ing negative emotions and a better understanding of them-
selves. The brief intervention approach was chosen following 
consultation with service users and workers given considera-
tions about engagement with other psychotherapeutic groups, 
but the qualitative analysis suggested that a future study might 
consider a longer intervention, as several of the participants 
reported that they wanted more sessions. This, however, should 
be balanced against the good retention rates of the study that 
contrast to other similar yet longer interventions in the same 
population.37
The study was not powered to detect clinical change, and 
pilot and feasibility studies have been criticised for relying on 
inferential statistics and hypothesis testing when they are 
underpowered to detect clinically meaningful effects.38 It has 
therefore been suggested that examining effect sizes and 
reporting the mean differences and CIs can be more informa-
tive to identify whether the intervention is worth taking for-
ward to a larger, randomised controlled trial.36 We performed 
exploratory analyses guided by these principles. We found that, 
on the OCDUS, the compassion group not only rated them-
selves as having higher desire for opioids following the inter-
vention but also rated themselves as making more effort to 
resist the urge to use opioids, compared with the waitlist con-
trol group. These findings were in opposite directions, and may 
be treated with caution given the limited scope of this pilot 
study to address clinical questions. Tentatively, we might inter-
pret these findings as reflecting the enhanced desire to use 
drugs as part of the difficult feelings that CFT may bring up in 
individuals, which might further suggest the need for a longer 
intervention. Theoretically, CFT helps individuals engage with 
feelings of disconnection and loneliness which underlie drug 
use, and therefore, an increase in craving for drugs in the early 
stages of therapy might be predicted as a function of enhanced 
awareness of these issues. Resistance may come as a function of 
enhanced urges to use, and any future study should assess actual 
drug use using objective measures to examine whether CFT 
produced increases in drug use in these groups. In our explora-
tory quantitative analysis, we also observed a reduction in 
depression across all groups in the study, likely either a function 
of regression to the mean or of being in a research study. Stress 
and anxiety appeared to reduce in the relaxation group com-
pared with the compassion group, but there no differences 
between the compassion and waitlist controls. Relaxation is an 
effective therapy in the short term in addiction and this likely 
mediated these changes. Overall, these quantitative measures 
were feasible to use in this setting and a future adequately pow-
ered trial can assess the impact of CFT on these outcomes.
Although the study was not powered to detect clinical out-
comes, the current project observed overall declines in depres-
sion and stress in all 3 groups. It is possible this may be a result 
of regression to the mean: where participants’ ratings on these 
scales are more extreme at baseline, and closer to the average at 
follow-up. The relaxation group performed equally well as the 
compassion group in depression and showed a greater reduc-
tion in anxiety, which is perhaps to be expected with an inter-
vention like relaxation that targets anxiety and is effective over 
a short time frame. In a fully powered clinical trial, it would be 
interesting to see whether a longer compassion intervention 
would be able to replicate the enhanced outcomes following 
compassion compared with relaxation that have been observed 
in other clinical groups.39
One limitation of the study is its scope and small sample 
size. However, we have been able to assess the feasibility of this 
design, which was the primary aim of the study. Although ther-
apists were supervised by a clinician who was experienced in 
CFT, another limitation was the absence of checks of fidelity 
to CFT treatment. Another limitation is that much of the con-
tent focused on psychoeducation around compassion and CFT 
generally, and might have further emphasised how the people 
involved might use compassionate practises to cope with their 
opioid use. Indeed, one suggestion of a future direction, rather 
than using compassionate body scans, would be to get users to 
imagine compassionate opioid practices where people imagine 
feeling craving for opioids and then switch to compassionate 
mind states and focus on imagining themselves resisting or 
reducing. One strength of this study is the use of 2 control 
groups, including an active comparator group to investigate the 
feasibility of such a trial design. The active groups were care-
fully matched in time and duration of sessions, and contained 
an equal balance of psychoeducation and experiential exercises. 
This design, if followed through to a fully powered trial, would 
enable us to understand the relative benefits of CFT in com-
parison with a similarly structured intervention, as well as the 
absolute benefits when compared with no treatment.40
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Conclusion
The use of CFT as an intervention for those with opioid addic-
tion is feasible and has high adherence rates. The quantitative 
data do not suggest a positive effect of this brief intervention 
over relaxation therapy and there was some suggestion of a 
greater desire to use opioids at the end of the intervention 
which is concerning. Future work should explore whether this 
increase in craving is related to increased drug use, which may 
suggest a limited use for this therapy in this group. Qualitative 
reports from users, however, suggested some observed benefits 
and a desire for more sessions of the self-compassion interven-
tion. Overall, these results indicate this new treatment to be 
feasible, and careful consideration should be given as to whether 
this should be systematically investigated in a higher powered, 
randomised control trial.
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